相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Platelet reactivity and clinical outcomes in patients using CYP3A4-metabolized statins with clopidogrel in percutaneous coronary intervention
Jin Sup Park et al.
HEART AND VESSELS (2017)
Effects of statin therapy on platelet reactivity after percutaneous coronary revascularization in patients with acute coronary syndrome
Anna Toso et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2017)
Platelet reactivity in response to loading dose of atorvastatin or rosuvastatin in patients with stable coronary disease before percutaneous coronary intervention: The STATIPLAT randomized study
Cosmo Godino et al.
CLINICAL CARDIOLOGY (2017)
Pleiotropic Effects of Statins on the Cardiovascular System
Adam Oesterle et al.
CIRCULATION RESEARCH (2017)
Omeprazole and atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation in patients undergoing percutaneous coronary intervention in a tertiary health care system: A prospective drug-drug interaction study
Jinesh Bahubali Nagavi et al.
IJC METABOLIC & ENDOCRINE (2016)
Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention
Rolf P. Kreutz et al.
CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS (2016)
Efficacy of Clopidogrel and Clinical Outcome When Clopidogrel Is Coadministered With Atorvastatin and Lansoprazole A Prospective, Randomized, Controlled Trial
Jian-rong Zhang et al.
MEDICINE (2015)
Early high-dose rosuvastatin and cardioprotection in the Protective effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome (PRATO-ACS) study
Mario Leoncini et al.
AMERICAN HEART JOURNAL (2014)
Interaction of clopidogrel and statins in secondary prevention after cerebral ischaemia - a randomized, double-blind, double-dummy crossover study
Timo Siepmann et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Pharmacodynamic effects of atorvastatin versus rosuvastatin in coronary artery disease patients with normal platelet reactivity while on dual antiplatelet therapy-The PEARL randomized cross-over study
Francesco Pelliccia et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Relationship Between Statin Type and Responsiveness to Clopidogrel in Patients Treated with Percutaneous Coronary Intervention: A Subgroup Analysis of the CILON-T Trial
Jung-Won Suh et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2014)
High-Dose Atorvastatin on the Pharmacodynamic Effects of Double-Dose Clopidogrel in Patients Undergoing Percutaneous Coronary Interventions The ACHIDO (Atorvastatin and Clopidogrel High Dose in stable patients with residual high platelet activity) Study
Mario Leoncini et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2013)
Concomitant Administration of Clopidogrel With Statins or Calcium-Channel Blockers Insights From the TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38)
Oluseyi Ojeifo et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2013)
Concomitant use of clopidogrel and statins and risk of major adverse cardiovascular events following coronary stent implantation
Morten Schmidt et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Genetic determinants of response to cardiovascular drugs
Quinn S. Wells et al.
CURRENT OPINION IN CARDIOLOGY (2012)
Statins have an early antiplatelet effect in patients with acute myocardial infarction
Shlomi Matetzky et al.
PLATELETS (2011)
Comparison of the efficacy of rosuvastatin versus atorvastatin in reducing apolipoprotein B/apolipoprotein A-1 ratio in patients with acute coronary syndrome: Results of the CENTAURUS study
Jean-Marc Lablanche et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2010)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Response to antiplatelet treatment: from genes to outcome
Betti Giusti et al.
LANCET (2010)
A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents
Peter Wenaweser et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Factors Influencing Clopidogrel Efficacy in Patients With Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Intervention: Statin's Advantage and the Smoking Paradox
Zuzana Motovska et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2009)
Influence of statin treatment on platelet inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment
R. E. Malmstrom et al.
JOURNAL OF INTERNAL MEDICINE (2009)
Effects of rosuvastatin on platelet inhibition by clopidogrel in cardiovascular patients
Silvia Riondino et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2009)
Investigation of an interaction between statins and clopidogrel after percutaneous coronary intervention: a cohort study
Ana Blagojevic et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)
High-dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients - A Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) analysis
Amir Lotfi et al.
AMERICAN HEART JOURNAL (2008)
Statins do not adversely affect post-interventional residual platelet aggregation and outcomes in patients undergoing coronary stenting treated by dual antiplatelet therapy
Tobias Geisleri et al.
EUROPEAN HEART JOURNAL (2008)
Impact of cytochrome P450 3A4-metabolized statins on the antiplatelet effect of a 600-mg loading dose clopidogrel and on clinical outcome in patients undergoing elective coronary stent placement
Dietmar Trenk et al.
THROMBOSIS AND HAEMOSTASIS (2008)
Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial
Jacqueline Saw et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease - Results of the Optimizing antiPlatelet Therapy In diabetes MellitUS (OPTIMUS) study
Dominick J. Angiolillo et al.
CIRCULATION (2007)
Effect of atorvastatin and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary Stent thrombosis
Peter Wenaweser et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Platelet response to clopidogrel is attenuated in diabetic patients undergoing coronary stent implantation
Tobias Geisler et al.
DIABETES CARE (2007)
A pharmacoepidemiology study of the interaction between atorvastatin and clopidogrel after percutaneous coronary intervention
James M. Brophy et al.
AMERICAN HEART JOURNAL (2006)
The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes
JV Mitsios et al.
PLATELETS (2005)
Not all statins interfere with clopidogrel during antiplatelet therapy
F Mach et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2005)
Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry
MJ Lim et al.
EUROPEAN HEART JOURNAL (2005)
Lack of clopidogrel-CYP3A4 statin interaction in patients with acute coronary syndrome
D Mukherjee et al.
HEART (2005)
Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes
JV Mitsios et al.
CIRCULATION (2004)
ADP induced platelet degranulation in healthy individuals is reduced by clopidogrel after pretreatment with atorvastatin
M Piorkowski et al.
THROMBOSIS AND HAEMOSTASIS (2004)
Multiple antiplatelet effects of clopidogrel are not modulated by statin type in patients undergoing percutaneous coronary intervention
SMG Smith et al.
PLATELETS (2004)
Antiplatlet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to cononary artery stenting
O Gorchakova et al.
EUROPEAN HEART JOURNAL (2004)
Absence of interaction between atorvastatin or other statins and clopidogrel - Results from the interaction study
VL Serebruany et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Effects of statins on platelet inhibition by a high loading dose of clopidogrel
I Müller et al.
CIRCULATION (2003)
Lipophilic statins interfere with the inhibitory effects of clopidogrel on platelet function -: a flow cytometry study
H Neubauer et al.
EUROPEAN HEART JOURNAL (2003)
Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial
J Saw et al.
CIRCULATION (2003)
Comparison of clinical benefits of clopidogrel therapy in patients with acute coronary syndromes taking atorvastatin versus other statin therapies
H Wienbergen et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation - A new drug-drug interaction
WC Lau et al.
CIRCULATION (2003)
The metabolism of clopidogrel is catalyzed by human cytochrome P450 3A and is inhibited by atorvastatin
TA Clarke et al.
DRUG METABOLISM AND DISPOSITION (2003)
Statin treatment following coronary artery stenting and one-year survival
A Schömig et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Statins do not affect platelet inhibition with clopidogrel during coronary stenting
VL Serebruany et al.
ATHEROSCLEROSIS (2001)
Identification and biological activity of the active metabolite of clopidogrel
P Savi et al.
THROMBOSIS AND HAEMOSTASIS (2000)
分享论文
